Inhibitory effects of progesterone differ in dendritic cells from female and male rodents

Gender Medicine

Volumn 5, Issue 4, 2008, Pages 434-447

  Butts, Cherié L ^a   Bowers, Eve ^a,b   Horn, J Cash ^a   Shukair, Shetha A ^a   Belyavskaya, Elena ^a   Tonelli, Leonardo ^c   Sternberg, Esther M ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

cytokines; gender differences; immunomodulation; steroid hormone receptors

Indexed keywords

ANDROGEN RECEPTOR; CYTOKINE; GLUCOCORTICOID RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; PROGESTERONE; STEROID RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BONE MARROW; CELL FUNCTION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENETIC TRANSCRIPTION; HORMONE ACTION; HORMONE RESPONSE; IMMUNOMODULATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RODENT; SEX DIFFERENCE;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; ANTIGENS; BONE MARROW CELLS; CELL SEPARATION; CELLS, CULTURED; COCULTURE TECHNIQUES; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INTERLEUKIN-10; INTERLEUKIN-1BETA; MALE; PROGESTERONE; PROGESTINS; RATS; RATS, INBRED F344; RECEPTORS, PROGESTERONE; RNA, MESSENGER; SEX CHARACTERISTICS; SPLEEN; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 57649228431     PISSN: 15508579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.genm.2008.11.001     Document Type: Article

References (45)

1. Verthelyi D. Sex hormones as immunomodulators in health and disease. Int Immunopharmacol 1 (2001) 983-993
2. Butts C., and Sternberg E. Different approaches to understanding autoimmune rheumatic diseases: The neuroimmunoendocrine system. Best Pract Res Clin Rheumatol 18 (2004) 125-139
3. Whitacre C.C. Sex differences in autoimmune disease. Nat Immunol. 2 (2001) 777-780
4. Moser M., and Murphy K.M. Dendritic cell regulation of TH1-TH2 development. Nat Immunol. 1 (2000) 199-205
5. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
6. Jiang H., Hou L., Qiao H., et al. Administration of tolerogenic dendritic cells induced by interleukin-10 prolongs rat splenic allograft survival. Transplant Proc. 36 (2004) 3255-3259
7. Zhang Z., Li S., Zhang L., et al. The characteristics of tolerogenic plasmacytoid dendritic cells stimulated with interleukin-3. Transplant Proc. 37 (2005) 7-9
8. Riboldi E., Musso T., Moroni E., et al. Cutting edge: Proangiogenic properties of alternatively activated dendritic cells. J Immunol. 175 (2005) 2788-2792
9. Zeyda M., Saemann M.D., Stuhlmeier K.M., et al. Polyunsaturated fatty acids block dendritic cell activation and function independently of NF-kappaB activation. J Biol Chem. 280 (2005) 14293-14301
10. Kalady M.F., Onaitis M.W., Emani S., et al. Sequential delivery of maturation stimuli increases human dendritic cell IL-12 production and enhances tumor antigen-specific immunogenicity. J Surg Res. 116 (2004) 24-31
11. Kelsall B.L., Stuber E., Neurath M., and Strober W. Interleukin-12 production by dendritic cells. The role of CD40-CD40L interactions in Th1 T-cell responses. Ann N Y Acad Sci. 795 (1996) 116-126
12. Zhou L.J., and Tedder T.F. A distinct pattern of cytokine gene expression by human CD83+ blood dendritic cells. Blood 86 (1995) 3295-3301
13. Healey G.D., Elvin S.J., Morton M., and Williamson E.D. Humoral and cell-mediated adaptive immune responses are required for protection against Burkholderia pseudomallei challenge and bacterial clearance postinfection. Infect Immun. 73 (2005) 5945-5951
14. Nehete P.N., Nehete B.P., Manuri P., et al. Protection by dendritic cells-based HIV synthetic peptide cocktail vaccine: Preclinical studies in the SHIV-rhesus model. Vaccine 23 (2005) 2154-2159
15. Nikolic T., Geutskens S.B., van Rooijen N., et al. Dendritic cells and macrophages are essential for the retention of lymphocytes in (peri)-insulitis of the nonobese diabetic mouse: A phagocyte depletion study. Lab Invest 85 (2005) 487-501
16. Kelsall B.L., Biron C.A., Sharma O., and Kaye P.M. Dendritic cells at the host-pathogen interface. Nat Immunol. 3 (2002) 699-702
17. Pulendran B. Variegation of the immune response with dendritic cells and pathogen recognition receptors. J Immunol. 174 (2005) 2457-2465
18. Frankenberger B., Regn S., Geiger C., et al. Cellbased vaccines for renal cell carcinoma: Geneticallyengineered tumor cells and monocyte-derived dendritic cells. World J Urol. 23 (2005) 166-174
19. Kuipers H., and Lambrecht B.N. Modification of dendritic cell function as a tool to prevent and treat allergic asthma. Vaccine 23 (2005) 4577-4588
20. Mizumoto N., Gao J., Matsushima H., et al. Discovery of novel immunostimulants by dendritic cell-based functional screening. Blood 106 (2005) 3082-3089
21. Chen M., Wang Y.H., Wang Y., et al. Dendritic cell apoptosis in the maintenance of immune tolerance. Science 311 (2006) 1160-1164
22. Lydon J.P., DeMayo F.J., Funk C.R., et al. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev. 9 (1995) 2266-2278
23. Graziano V., Check J.H., Dietterich C., et al. A comparison of luteal phase support in graduated estradiol/progesterone replacement cycles using intramuscular progesterone alone versus combination with vaginal suppositories on outcome following frozen embryo transfer. Clin Exp Obstet Gynecol 32 (2005) 93-94
24. Mizutani T., Sugihara A., Honma H., et al. Effect of steroid add-back therapy on the proliferative activity of uterine leiomyoma cells under gonadotropinreleasing hormone agonist therapy. Gynecol Endocrinol 20 (2005) 80-83
25. Bachelot A., and Binart N. Corpus luteum development: Lessons from genetic models in mice. Curr Top Dev Biol. 68 (2005) 49-84
26. Couse J.F., Yates M.M., Deroo B.J., and Korach K.S. Estrogen receptor-beta is critical to granulosa cell differentiation and the ovulatory response to gonadotropins. Endocrinology 146 (2005) 3247-3262
27. Ismail P.M., Amato P., Soyal S.M., et al. Progesterone involvement in breast development and tumorigenesis-as revealed by progesterone receptor "knockout" and "knockin" mouse models. Steroids 68 (2003) 779-787
28. Smuc T., Pucelj M.R., Sinkovec J., et al. Expression analysis of the genes involved in estradiol and progesterone action in human ovarian endometriosis. Gynecol Endocrinol 23 (2007) 105-111
29. Stites D.P., and Siiteri P.K. Steroids as immunosuppressants in pregnancy. Immunol Rev. 75 (1983) 117-138
30. Wieser F., Hosmann J., Tschugguel W., et al. Progesterone increases the number of Langerhans cells in human vaginal epithelium. Fertil Steril. 75 (2001) 1234-1235
31. Mingjia L., and Short R. How oestrogen or progesterone might change a woman's susceptibility to HIV-1 infection. Aust N Z J Obstet Gynaecol. 42 (2002) 472-475
32. Miyaura H., and Iwata M. Direct and indirect inhibition of Th1 development by progesterone and glucocorticoids. J Immunol. 168 (2002) 1087-1094
33. Butts C.L., Shukair S.A., Duncan K.M., et al. Progesterone inhibits mature rat dendritic cells in a receptor-mediated fashion. Int Immunol. 19 (2007) 287-296
34. Wan H., Versnel M.A., Leijten L.M., et al. Chorionic gonadotropin induces dendritic cells to express a tolerogenic phenotype. J Leukoc Biol. 83 (2008) 894-901
35. Muller E., and Kerschbaum H.H. Progesterone and its metabolites 5-dihydroprogesterone and 5-3-tetrahydroprogesterone decrease LPS-induced NO release in the murine microglial cell line, BV-2. Neuro Endocrinol Lett. 27 (2006) 675-678
36. Talmor M., Mirza A., Turley S., et al. Generation or large numbers of immature and mature dendritic cells from rat bone marrow cultures. Eur J Immunol. 28 (1998) 811-817
37. Lapointe R., Toso J.F., Butts C., et al. Human dendritic cells require multiple activation signals for the efficient generation of tumor antigen-specific T lymphocytes. Eur J Immunol. 30 (2000) 3291-3298
38. Chun H.Y., Chung J.W., Kim H.A., et al. Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus. J Clin Immunol. 27 (2007) 461-466
39. Vital P., Larrieta E., and Hiriart M. Sexual dimorphism in insulin sensitivity and susceptibility to develop diabetes in rats. J Endocrinol 190 (2006) 425-432
40. Oztas B., Akgul S., and Seker F.B. Gender difference in the influence of antioxidants on the blood-brain barrier permeability during pentylenetetrazolinduced seizures in hyperthermic rat pups. Biol Trace Elem Res. 118 (2007) 77-83
41. Khasar S.G., Dina O.A., Green P.G., and Levine J.D. Estrogen regulates adrenal medullary function producing sexual dimorphism in nociceptive threshold and beta-adrenergic receptor-mediated hyperalgesia in the rat. Eur J Neurosci. 21 (2005) 3379-3386
42. Green P.G., Dahlqvist S.R., Isenberg W.M., et al. Role of adrenal medulla in development of sexual dimorphism in inflammation. Eur J Neurosci. 14 (2001) 1436-1444
43. Vottero A., Pedori S., Verna M., et al. Final height in girls with central idiopathic precocious puberty treated with gonadotropin-releasing hormone analog and oxandrolone. J Clin Endocrinol Metab. 91 (2006) 1284-1287
44. Janssen O.E., Mehlmauer N., Hahn S., et al. High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. Eur J Endocrinol 150 (2004) 363-369
45. Gleicher N., Barad D., and Weghofer A. Functional autoantibodies, a new paradigm in autoimmunity?. Autoimmun Rev. 7 (2007) 42-45